213 related articles for article (PubMed ID: 11814781)
21. PET imaging of amyloid in Alzheimer's disease.
Nordberg A
Lancet Neurol; 2004 Sep; 3(9):519-27. PubMed ID: 15324720
[TBL] [Abstract][Full Text] [Related]
22. Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography.
Klunk WE; Engler H; Nordberg A; Bacskai BJ; Wang Y; Price JC; Bergström M; Hyman BT; Långström B; Mathis CA
Neuroimaging Clin N Am; 2003 Nov; 13(4):781-9, ix. PubMed ID: 15024961
[TBL] [Abstract][Full Text] [Related]
23. Investigation of the Binding Profiles of AZD2184 and Thioflavin T with Amyloid-β(1-42) Fibril by Molecular Docking and Molecular Dynamics Methods.
Kuang G; Murugan NA; Tu Y; Nordberg A; Ågren H
J Phys Chem B; 2015 Sep; 119(35):11560-7. PubMed ID: 26266837
[TBL] [Abstract][Full Text] [Related]
24. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of 2-(3'-iodo-4'-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease.
Wang Y; Klunk WE; Huang GF; Debnath ML; Holt DP; Mathis CA
J Mol Neurosci; 2002; 19(1-2):11-6. PubMed ID: 12212766
[TBL] [Abstract][Full Text] [Related]
26. Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease.
Kudo Y
Minim Invasive Ther Allied Technol; 2006; 15(4):209-13. PubMed ID: 16966133
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and fluorescence lifetime study of benzothiazole derivatives for imaging of amyloids.
Kumar N; Tiwari AK; Kakkar D; Saini N; Chand M; Mishra AK
Cancer Biother Radiopharm; 2010 Oct; 25(5):571-5. PubMed ID: 20874487
[TBL] [Abstract][Full Text] [Related]
28. Novel ¹⁸F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in Alzheimer's disease.
Cui M; Ono M; Kimura H; Ueda M; Nakamoto Y; Togashi K; Okamoto Y; Ihara M; Takahashi R; Liu B; Saji H
J Med Chem; 2012 Nov; 55(21):9136-45. PubMed ID: 22690944
[TBL] [Abstract][Full Text] [Related]
29. Radiolabeled bioactive benzoheterocycles for imaging β-amyloid plaques in Alzheimer's disease.
Yang Y; Cui M
Eur J Med Chem; 2014 Nov; 87():703-21. PubMed ID: 25305715
[TBL] [Abstract][Full Text] [Related]
30. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain.
Klunk WE; Wang Y; Huang GF; Debnath ML; Holt DP; Mathis CA
Life Sci; 2001 Aug; 69(13):1471-84. PubMed ID: 11554609
[TBL] [Abstract][Full Text] [Related]
31. IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques.
Kung MP; Hou C; Zhuang ZP; Zhang B; Skovronsky D; Trojanowski JQ; Lee VM; Kung HF
Brain Res; 2002 Nov; 956(2):202-10. PubMed ID: 12445687
[TBL] [Abstract][Full Text] [Related]
32. Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives.
Wang Y; Mathis CA; Huang GF; Debnath ML; Holt DP; Shao L; Klunk WE
J Mol Neurosci; 2003; 20(3):255-60. PubMed ID: 14501005
[TBL] [Abstract][Full Text] [Related]
33. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice.
Bacskai BJ; Hickey GA; Skoch J; Kajdasz ST; Wang Y; Huang GF; Mathis CA; Klunk WE; Hyman BT
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12462-7. PubMed ID: 14517353
[TBL] [Abstract][Full Text] [Related]
34. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
[TBL] [Abstract][Full Text] [Related]
35. Novel styrylpyridines as probes for SPECT imaging of amyloid plaques.
Qu W; Kung MP; Hou C; Benedum TE; Kung HF
J Med Chem; 2007 May; 50(9):2157-65. PubMed ID: 17411026
[TBL] [Abstract][Full Text] [Related]
36. Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI.
Huddleston DE; Small SA
Nat Clin Pract Neurol; 2005 Dec; 1(2):96-105. PubMed ID: 16932505
[TBL] [Abstract][Full Text] [Related]
37. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
38. Biological evaluation of the radioiodinated imidazo[1,2-a]pyridine derivative DRK092 for amyloid-β imaging in mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Morimoto Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Suhara T; Higuchi M; Yamada K; Ji B
Neurosci Lett; 2014 Oct; 581():103-8. PubMed ID: 25172571
[TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis, and Validation of a Novel [
Whitmore CA; Boules MI; Behof WJ; Haynes JR; Koktysh D; Rosenberg AJ; Tantawy MN; Pham W
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920113
[TBL] [Abstract][Full Text] [Related]
40. Fluselenamyl: A Novel Benzoselenazole Derivative for PET Detection of Amyloid Plaques (Aβ) in Alzheimer's Disease.
Sundaram GS; Dhavale DD; Prior JL; Yan P; Cirrito J; Rath NP; Laforest R; Cairns NJ; Lee JM; Kotzbauer PT; Sharma V
Sci Rep; 2016 Nov; 6():35636. PubMed ID: 27805057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
